Psychodynamic Motivation and Training program (PMT) for the secondary prevention in patients with stable coronary heart disease: study protocol for a randomized controlled trial of feasibility and effects

Trials

Manfred E Beutel⁴  Thomas Münzel⁵  Josef Unterrainer¹  Björn Sterzing²  Suzan Tug²  Jörg Wiltink⁴  Philipp S Wild⁵  Jochem König³  Tommaso Gori⁵  Perikles Simon²  Matthias Michal⁴ 

[1] Institute of Medical Psychology and Sociology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany;Department of Sports Medicine, Rehabilitation and Disease Prevention, Institute for Sport Sciences, Johannes Gutenberg University Mainz, Mainz, Germany;Institute of Medical Biostatistics, Epidemiology & Informatics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany;Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg University Mainz, Untere Zahlbacher Strasse 8, Mainz 55131, Germany;Department of Medicine II, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

关键词: Motivation;    Spiroergometry;    Secondary prevention;    Home based exercise training;    Physical activity;    Coronary heart disease;    Psychodynamic psychotherapy;   

Others  :  1092987
DOI  :  10.1186/1745-6215-14-314

 received in 2013-06-03, accepted in 2013-09-16,  发布年份 2013

【 摘 要 】

Background

Nonpharmacological secondary prevention of coronary heart disease is considered a safe and effective measure to substantially reduce mortality. Despite the effectiveness of lifestyle changes, the compliance rate of patients is very low mainly due to psychosocial barriers. Psychotherapeutic approaches that address how persons think about themselves and their behaviors appear to have a significant potential for improving health behavior.

Methods/design

Against this background, our study aims to examine the feasibility and effects of a Psychodynamic Motivation and Training program (PMT) as compared to one session of advice in exercise training (EX) and treatment as usual (TAU). For that purpose, 90 patients with stable coronary heart disease and a physically inactive lifestyle will be randomly assigned to the three groups (each with n = 30). The primary outcome is the change in the individual anaerobic threshold as determined by spiroergometry from baseline to six month follow-up. Secondary endpoints include change in endothelial function, biomarkers of inflammation and oxidative stress, quality of life, symptoms of fatigue, illness perception and feasibility of the treatment approach. We hypothesize that physical fitness will improve more in PMT than in EX and TAU, with PMT and EX more than TAU, and that the effects will be more pronounced for participants with current mental or psychosocial distress.

Discussion

The results of the study will help to determine the effectiveness of a psychodynamic lifestyle change approach and to identify measures for designing specifically tailored interventions to improve compliance with cardiovascular prevention.

Trial registration

ClinicalTrials.gov Identifier: NCT01445808

【 授权许可】

   
2013 Michal et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012, 33(13):1635-1701.
• [2]Hamer M: Psychosocial stress and cardiovascular disease risk: the role of physical activity. Psychosom Med 2012, 74(9):896-903.
• [3]Blumenthal JA, Sherwood A, Babyak MA, Watkins LL, Smith PJ, Hoffman BM, O’Hayer CV, Mabe S, Johnson J, Doraiswamy PM, et al.: Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol 2012, 60(12):1053-1063.
• [4]Blumenthal JA, Babyak MA, O’Connor C, Keteyian S, Landzberg J, Howlett J, Kraus W, Gottlieb S, Blackburn G, Swank A, et al.: Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA 2012, 308(5):465-474.
• [5]Smedt DD, Clays E, Annemans L, Boudrez H, Sutter JD, Doyle F, Jennings C, Kotseva K, Pajak A, Pardaens S, et al.: The association between self-reported lifestyle changes and health-related quality of life in coronary patients: the EUROASPIRE III survey. Eur J Prev Cardiol 2013. in press; doi:10.1177/2047487312473846
• [6]Teo K, Lear S, Islam S, Mony P, Dehghan M, Li W, Rosengren A, Lopez-Jaramillo P, Diaz R, Oliveira G, et al.: Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: The Prospective Urban Rural Epidemiology (PURE) study. JAMA 2013, 309(15):1613-1621.
• [7]Muller-Riemenschneider F, Damm K, Meinhard C, Bockelbrink A, Vauth C, Willich SN, Greiner W: Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease. GMS Health Technol Assess 2009, 5:Doc16.
• [8]Müller-Riemenschneider F, Damm K, Meinard C, Bockelbrink A, Vauth C, Willich S, Greiner G: Nichtmedikamentöse Sekundärprävention der koronaren Herzkrankheit (KHK). Volume 95. Köln: DIMDI: Schriftenreihe Health Technology Assessment, Bd; 2009.
• [9]Rogerson MC, Murphy BM, Bird S, Morris T: “I don’t have the heart”: a qualitative study of barriers to and facilitators of physical activity for people with coronary heart disease and depressive symptoms. Int J Behav Nutr Phys Act 2012, 9:140. BioMed Central Full Text
• [10]Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, Kumanyika S, Kraus WE, Fleg JL, Redeker NS, et al.: Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 2010, 122(4):406-441.
• [11]Norcross JC: Psychotherapy relationships that work: Therapist contributions and responsiveness to patients. USA: Oxford University Press; 2002.
• [12]Petti S: Lifestyle risk factors for oral cancer. Oral Oncol 2009, 45(4–5):340-350.
• [13]Eberth B, Olajide D, Craig P, Ludbrook A: Smoking-related disease risk, area deprivation and health behaviors. J Public Health (Oxf) 2013. in press; doi:10.1093/pubmed/fdt031
• [14]Stringhini S, Tabak AG, Akbaraly TN, Sabia S, Shipley MJ, Marmot MG, Brunner EJ, Batty GD, Bovet P, Kivimaki M: Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ 2012, 345:e5452.
• [15]Michal M, Wiltink J, Reiner I, Kirschner Y, Wild PS, Schulz A, Zwiener I, Blettner M, Beutel ME: Association of mental distress with smoking status in the community: results from the Gutenberg Health Study. J Affect Disord 2012, 146(3):355-360.
• [16]Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJ, Martin BW: Correlates of physical activity: why are some people physically active and others not? Lancet 2012, 380(9838):258-271.
• [17]Whooley MA, de Jonge P, Vittinghoff E, Otte C, Moos R, Carney RM, Ali S, Dowray S, Na B, Feldman MD, et al.: Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008, 300(20):2379-2388.
• [18]Ye S, Muntner P, Shimbo D, Judd SE, Richman J, Davidson KW, Safford MM: Behavioral mechanisms, elevated depressive symptoms, and the risk for myocardial infarction or death in individuals with coronary heart disease: the REGARDS (Reason for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol 2013, 61(6):622-630.
• [19]Berk M, Sarris J, Coulson CE, Jacka FN: Lifestyle management of unipolar depression. Acta Psychiatr Scand Suppl 2013, 443:38-54.
• [20]Blumenthal JA: Targeting lifestyle change in patients with depression. J Am Coll Cardiol 2013, 61(6):631-634.
• [21]Albus C, Beutel ME, Deter HC, Fritzsche K, Hellmich M, Jordan J, Juenger J, Krauth C, Ladwig KH, Michal M, et al.: A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD) - rationale and design of a multicenter, randomized trial in depressed patients with CAD. J Psychosom Res 2011, 71(4):215-222.
• [22]Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bauman A: Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116(9):1081-1093.
• [23]Heidenreich T, Tuin I, Pflug B, Michal M, Michalak J: Mindfulness-based cognitive therapy for persistent insomnia: a pilot study. Psychother Psychosom 2006, 75(3):188-189.
• [24]McCullough L, Kuhn N, Andrews S: Treating Affect Phobia: A Manual for Short-Term Dynamic Psychotherapy: A Manual for Short-term Dynamic Psychotherapy. New York: Guilford Pubn; 2003.
• [25]Katon W, Lin EH, Von Korff M, Ciechanowski P, Ludman E, Young B, Rutter C, Oliver M, McGregor M: Integrating depression and chronic disease care among patients with diabetes and/or coronary heart disease: the design of the TEAMcare study. Contemp Clin Trials 2010, 31(4):312-322.
• [26]Dickhuth HH, Yin L, Niess A, Rocker K, Mayer F, Heitkamp HC, Horstmann T: Ventilatory, lactate-derived and catecholamine thresholds during incremental treadmill running: relationship and reproducibility. Int J Sports Med 1999, 20(2):122-127.
• [27]Roecker K, Striegel H, Dickhuth HH: Heart-rate recommendations: transfer between running and cycling exercise? Int J Sports Med 2003, 24(3):173-178.
• [28]Wasserman K, Hansen JE, Sue DY, Whipp BJ, Froelicher VF: Principles of exercise testing and interpretation. J Cardiopulm Rehabil Prev 1987, 7(4):189.
• [29]Beaver WL, Wasserman K, Whipp BJ: A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986, 60(6):2020-2027.
• [30]Cohn JN, Quyyumi AA, Hollenberg NK, Jamerson KA: Surrogate markers for cardiovascular disease: functional markers. Circulation 2004, 109(25 Suppl 1):IV31-IV46.
• [31]Gori T, Muxel S, Damaske A, Radmacher MC, Fasola F, Schaefer S, Schulz A, Jabs A, Parker JD, Munzel T: Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease. Eur Heart J 2012, 33(3):363-371.
• [32]Gori T, Dragoni S, Lisi M, Di Stolfo G, Sonnati S, Fineschi M, Parker JD: Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol 2008, 51(20):1953-1958.
• [33]Bartoli G, Menegaz G, Lisi M, Di Stolfo G, Dragoni S, Gori T: Model-based analysis of flow-mediated dilation and intima-media thickness. Int J Biomed Imaging 2008, 2008:738545.
• [34]EuroQol: EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol group. Health Policy 1990, 16(3):199-208.
• [35]Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonnell M, Fihn SD: Development and evaluation of the Seattle Angina questionnaire: a new functional status measure for coronary artery disease* 1. J Am Coll Cardiol 1995, 25(2):333-341.
• [36]Appels A, Hoppener P, Mulder P: A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol 1987, 17(1):15-24.
• [37]Smets E, Garssen B, Bonke B, De Haes J: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39(3):315-325.
• [38]Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM: A scale for the estimation of sleep problems in clinical research* 1. J Clin Epidemiol 1988, 41(4):313-321.
• [39]Broadbent E, Petrie KJ, Main J, Weinman J: The brief illness perception questionnaire. J Psychosom Res 2006, 60(6):631-637.
• [40]Petrie KJ, Cameron LD, Ellis CJ, Buick D, Weinman J: Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosom Med 2002, 64(4):580-586.
• [41]Baecke J, Burema J, Frijters J: A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36(5):936-942.
• [42]Spitzer RL, Williams JB, Kroenke K, Linzer M, DeGruy FV 3rd, Hahn SR, Brody D, Johnson JG: Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994, 272(22):1749-1756.
• [43]Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, Buchholz C, Witte S, Herzog W: Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 2004, 78(2):131-140.
• [44]Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146(5):317-325.
• [45]Kroenke K, Spitzer RL, Williams JB, Lowe B: The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry 2010, 32(4):345-359.
• [46]MacGregor KL, Funderburk JS, Pigeon W, Maisto SA: Evaluation of the PHQ-9 Item 3 as a screen for sleep disturbance in primary care. J Gen Intern Med 2012, 27(3):339-344.
• [47]Lowe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brahler E: A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord 2010, 122(1–2):86-95.
• [48]Skapinakis P: The 2-item generalized anxiety disorder scale had high sensitivity and specificity for detecting GAD in primary care. Evid Based Med 2007, 12(5):149.
• [49]Pedersen SS, Denollet J, de Jonge P, Simsek C, Serruys PW, van Domburg RT: Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting. J Gen Intern Med 2009, 24(9):1037-1042.
• [50]Kaller CP JMU, Kaiser S, Weisbrod M: Tower of London - Freiburger Version. Mödling: Schuhfried; 2011.
• [51]Kaller CP, Rahm B, Kostering L, Unterrainer JM: Reviewing the impact of problem structure on planning: a software tool for analyzing tower tasks. Behav Brain Res 2011, 216(1):1-8.
• [52]Keith Berg W, Byrd D: The tower of London spatial problem-solving task: enhancing clinical and research implementation. J Clin Exp Neuropsychol 2002, 24(5):586-604.
• [53]Kaller CP, Unterrainer JM, Stahl C: Assessing planning ability with the tower of London task: psychometric properties of a structurally balanced problem set. Psychol Assess 2012, 24(1):46-53.
• [54]Chang YK, Ku PW, Tomporowski PD, Chen FT, Huang CC: Effects of acute resistance exercise on late-middle-age adults’ goal planning. Med Sci Sports Exerc 2012, 44(9):1773-1779.
• [55]Chang YK, Chu IH, Chen FT, Wang CC: Dose–response effect of acute resistance exercise on tower of London in middle-aged adults. J Sport Exerc Psychol 2011, 33(6):866-883.
• [56]Fortini A, Bonechi F, Taddei T, Gensini GF, Malfanti PL, Neri Serneri GG: Anaerobic threshold in patients with exercise-induced myocardial ischemia. Circulation 1991, 83(5 Suppl):III50-III53.
• [57]Gitt AK, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M, Schneider S, Schwarz A, Senges J: Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation 2002, 106(24):3079-3084.
• [58]Corra U, Mezzani A, Bosimini E, Scapellato F, Imparato A, Giannuzzi P: Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 2002, 143(3):418-426.
• [59]Faude O, Kindermann W, Meyer T: Lactate threshold concepts: how valid are they? Sports Med 2009, 39(6):469-490.
• [60]Myers J, Hadley D, Oswald U, Bruner K, Kottman W, Hsu L, Dubach P: Effects of exercise training on heart rate recovery in patients with chronic heart failure. Am Heart J 2007, 153(6):1056-1063.
• [61]Valkeinen H, Aaltonen S, Kujala UM: Effects of exercise training on oxygen uptake in coronary heart disease: a systematic review and meta-analysis. Scand J Med Sci Sports 2010, 20(4):545-555.
• [62]Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, Fiore C, Harlow LL, Redding CA, Rosenbloom D, et al.: Stages of change and decisional balance for 12 problem behaviors. Health Psychol 1994, 13(1):39-46.
• [63]Norcross JC, Krebs PM, Prochaska JO: Stages of change. J Clin Psychol 2011, 67(2):143-154.
• [64]Montero D, Walther G, Benamo E, Perez-Martin A, Vinet A: Effects of Exercise Training on Arterial Function in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Sports Med 2013, 1-9. doi: 10.1007/s40279-013-0085-2
• [65]Spence AL, Carter HH, Naylor LH, Green DJ: A prospective randomized longitudinal study involving 6 months of endurance or resistance exercise. conduit artery adaptation in humans. J Physiol 2013, 591(Pt 5):1265-1275.
• [66]Black MA, Cable NT, Thijssen DH, Green DJ: Impact of age, sex, and exercise on brachial artery flow-mediated dilatation. Am J Physiol Heart Circ Physiol 2009, 297(3):H1109-H1116.
• [67]Franzoni F, Ghiadoni L, Galetta F, Plantinga Y, Lubrano V, Huang Y, Salvetti G, Regoli F, Taddei S, Santoro G, et al.: Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens 2005, 18(4 Pt 1):510-516.